Hoogenkamp, Denise S.
de Wit–van der Veen, Linda J.
Huizing, Daphne M. V.
Tesselaar, Margot E. T.
van Leeuwaarde, Rachel S.
Stokkel, Marcel P. M.
Lam, Marnix G. E. H.
Braat, Arthur J. A. T.
Article History
Accepted: 21 March 2024
First Online: 10 April 2024
Declarations
:
: The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: D.S. Hoogenkamp, B.J. de Wit–van der Veen, D.M.V. Huizing, M.E.T. Tesselaar, R.S. van Leeuwaarde, and M.P.M. Stokkel declare no conflict of interest. M.G.E.H. Lam has acted as a consultant for Boston Scientific and Terumo and receives research support from Novartis, Boston Scientific, and Terumo. A.J.A.T. Braat has acted as a consultant for Boston Scientific, GE Healthcare, and Terumo and receives research support from Ariceum Therapeutics. The UMC Utrecht receives research support and royalties from Terumo (Quiremspheres®).